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Abstract
Background The immediate impact of providing an antenatal dietary intervention during pregnancy has been extensively
studied, but little is known of the effects beyond the neonatal period. Our objective was to evaluate the effect of an antenatal
dietary intervention in overweight or obese women on infant outcomes 6 months after birth.
Methods We conducted a follow up study of infants born to women who participated in the LIMIT trial during pregnancy.
Live-born infants at 6-months of age, and whose mother provided consent to ongoing follow-up were eligible. The primary
follow-up study endpoint was the incidence of infant BMI z-score ≥90th centile for infant sex and age. Secondary study
outcomes included a range of infant anthropometric measures, neurodevelopment, general health, and infant feeding.
Analyses used intention to treat principles according to the treatment group allocated in pregnancy. Missing data were
imputed and analyses adjusted for maternal early pregnancy BMI, parity, study centre, socioeconomic status, age, and
smoking status. Outcome assessors were blinded to the allocated treatment group.
Results A total of 1754 infants were assessed at age 6 months (Lifestyle Advice n= 869; Standard Care n= 885), repre-
senting 82.1% of the eligible sample (n= 2136). There were no statistically signiﬁcant differences in the incidence of infant
BMI z-score ≥90th centile for infants born to women in the Lifestyle Advice group, compared with the Standard Care group
(Lifestyle Advice 233 (21.71%) vs. Standard Care 233 (21.90%); adjusted relative risk (aRR) 0.99; 95% conﬁdence interval
0.82 to 1.18; p= 0.88). There were no other effects on infant growth, adiposity, or neurodevelopment.
Conclusion Providing pregnant women who were overweight or obese with an antenatal dietary and lifestyle intervention
did not alter 6-month infant growth and adiposity. Trial Registration: Australian and New Zealand Clinical Trials Registry
(ACTRN12607000161426).
Introduction
Across the globe, >1.46 billion adults [1], and 170 million
children [2], are overweight or obese. It is well recognised
that a woman’s nutrition during pregnancy impacts preg-
nancy and birth outcomes, with the intra-uterine environ-
ment playing a key role in an individual’s later health and
disease [3]. Maternal obesity signiﬁcantly predicts child and
adult obesity in her offspring [4, 5], and associated cardio-
metabolic risk factors, including hypertension, hyperlipi-
daemia, diabetes, and cardiovascular disease [6–8]. Kit-
santas and colleagues [9] report that maternal pre-gravid
obesity increases the odds of pre-school obesity by a factor
of 1.6 (OR 1.60; 95% CI 1.26–2.03), while Rooney and
colleagues [10] report a substantially greater increase in risk
(RR 6.35; 95% CI 3.28–12.30). Exposure to such an
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intra-uterine environment potentially creates a vicious cycle
in which the propensity to obesity is perpetuated, with
major adverse public health implications [11, 12], and
implications for the health of successive generations [13].
There has been considerable research interest in the
provision of antenatal dietary interventions during preg-
nancy to limit weight gain and improve pregnancy and birth
outcomes for women and their infants. A comprehensive
systematic review by Thangaratinam and colleagues [14]
has identiﬁed numerous studies assessing dietary and life-
style interventions in pregnancy, albeit mostly small in
scope. While the ﬁndings reveal a relatively modest impact
on weight gain [14], very little attention has been directed
towards the ongoing follow-up of women and infants
beyond the neonatal period to assess longer term outcomes.
To our knowledge, only three randomised trials invol-
ving the provision of an antenatal dietary intervention [15–
17] have conducted and reported ﬁndings of follow-up to
6 months after birth [18–20]. However, these studies have
been limited by the relatively low rates of assessment [18–
20]. Furthermore, studies have focussed predominantly on
measures of adiposity, and have not reported other clinically
relevant infant outcomes [18, 20], or speciﬁcally reported
infant outcomes among women who are overweight or
obese [19].
We have previously shown that a comprehensive dietary
and lifestyle intervention during pregnancy, in women who
are overweight or obese, signiﬁcantly improves both
maternal diet and physical activity [21], is associated with
an 18 and 41% relative reduction in the risk of high infant
birth weight above 4 and 4.5 kg [22, 23], and was a cost
neutral intervention [24]. On-going participant follow-up is
required to assess the further impact of these ﬁndings on
childhood outcomes. This manuscript reports the effect of
the LIMIT antenatal dietary intervention, on 6-month infant
outcomes.
Methods
The methods and primary clinical ﬁndings of the LIMIT
randomised trial have been published [21–23], with the trial
registered on the Australian and New Zealand Clinical
Trials Registry (ACTRN12607000161426). Brieﬂy, we
conducted a multicentre randomised trial involving women
with a singleton pregnancy, between 10+0 and 20+0 weeks’
gestation, and body mass index ≥25.0 kg/m2, who were
randomised to either an antenatal dietary and lifestyle
intervention (Lifestyle Advice Group) or standard antenatal
care (Standard Care Group) [22].
Women in the Lifestyle Advice group received a com-
prehensive intervention over the course of their pregnancy
that included a combination of dietary, exercise and
behavioural strategies, delivered by a research dietician and
trained research assistants [22]. Dietary information was
consistent with current Australian standards [25], while
physical activity advice focussed on the beneﬁts of exercise
in pregnancy [26]. Women were encouraged to set
achievable goals for change, supported to make these life-
style changes, to identify potential barriers and enablers to
their implementation, and to self-monitor their progress [21,
22]. This information was delivered through two dedicated
sessions with the research dietician (at trial entry, and
28 weeks) and trained research assistants (via telephone call
at 22, 24, and 32 weeks, and a face–face visit at 36 weeks)
[21, 22].
Study design
We conducted follow-up of infants born to women who
participated in the LIMIT randomised trial 6-months after
birth.
Participants
Women who participated in the LIMIT randomised trial,
gave birth to a live infant, and who provided consent to the
ongoing follow-up of their child, were eligible for inclusion.
Women who suffered a stillbirth or neonatal death, or who
withdrew from participation in ongoing follow-up were
excluded.
Follow-up schedule
Each infant was assessed by a research assistant, blinded to
the allocated treatment group. Eligible women were con-
tacted to arrange a follow-up assessment of their child,
either at the hospital of their birth, or if more convenient, for
a research assistant to visit their home.
Primary outcome
The primary outcome was the incidence of infant BMI z-
score ≥90th centile for infant age and sex at follow-up [27].
Secondary outcomes
Infant Anthropometric Measurements: We have an estab-
lished and validated method of conducting anthropometric
measurements in infants [28]. Information obtained inclu-
ded the infant’s length, weight, weight-for-length, and
anthropometric measurements (arm, thigh, waist and hip
circumferences; biceps, triceps, sub-scapular, abdominal,
supra-iliac and thigh skin-fold thickness). Research assis-
tants used Harpenden skin-fold callipers to obtain skinfold
thickness measurements, and received ongoing standardised
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training [29]. Weight, length, BMI, weight-for-length, and
head circumference measures were converted to z-scores for
age and gender, using WHO standards [27, 30].
Infant Neurodevelopment: The infant’s primary caregiver
was asked to complete a structured Ages and Stages
Questionnaire (ASQ) [31], reporting ﬁve domains of
development (communication, gross motor, ﬁne motor,
problem solving, and personal-social skills). Possible
responses included Yes, Sometimes, or No, with a score in
any one domain >2SD below the mean considered indica-
tive of the need for further assessment and when identiﬁed,
the primary caregiver was advised to seek additional med-
ical advice. The ASQ has been validated against the Bayley
Scales [32], and in a paediatric population [33].
General health, health service utilisation, and quality of
life: as assessed by questionnaire [34] completed by the
infant’s primary caregiver.
Infant Feeding: (breast, formula, or a combination of the
two), as assessed by questionnaire completed by the infant’s
primary caregiver.
Sample size
The available sample size for follow-up assessment at 6-
months of age was predetermined by the LIMIT trial, which
was powered on the primary outcome of large for gesta-
tional age, with 2212 women randomised [22]. Using data
from the general Australian population, we anticipated a
minimum incidence in the standard care group of BMI z-
score ≥90th centile of approximately 25% [35]. A sample
size of 1350 infants (75% follow-up) would provide 80%
power to detect at least a difference in the incidence of BMI
z-score ≥90th centile of 6.4% (from 25 to 18.6%; alpha
0.05). Detectable differences would range from 6.2% (with
follow-up of 80% of children), to 6.7% (with follow-up of
70% of children; alpha 0.05; power 80%). Small but rele-
vant differences of 0.15–0.16 standard deviations in sec-
ondary continuous outcomes could also be detected.
Statistical analysis
The analysis was conducted using intention to treat princi-
ples, according to the treatment group the woman was
randomised to in pregnancy (Lifestyle Advice or Standard
Care). Missing data were imputed for all randomised par-
ticipants except those who had no live birth, who had an
infant death, or who withdrew from the study and also
withdrew permission to use data. Data were imputed sepa-
rately by treatment group using the fully conditional spe-
ciﬁcation (chained equations) method to create 100
complete datasets for analysis under the assumption that the
data were missing at random (i.e., that “missingness” was
independent of the values of the missing observations,
conditional on observed data). In order to make the MAR
assumption more plausible, a range of auxiliary variables,
including stratiﬁcation (centre, parity, BMI category) and
adjustment variables (socioeconomic status, smoking,
maternal age at consent, infant gender), along with infant
birth measures (weight, length, circumferences and skinfold
thickness measures), were included in the imputation
model. The results of imputed analyses were compared with
those from complete-case analyses, and further sensitivity
analyses were also conducted for the primary outcome on
the assumption that data were Missing Not At Random
(MNAR). That is, analyses were conducted assuming that
missing values had, ﬁrstly, a substantially greater incidence,
and secondly, a substantially reduced incidence of z-scores
>90th percentile as compared with the observed data.
Both adjusted and unadjusted analyses were performed,
with adjustment for variables used to stratify randomisation
(maternal early pregnancy BMI category, parity, and centre
of birth), in addition to maternal socioeconomic status, age,
and smoking status. Infant outcomes other than z-scores
were additionally adjusted for gender and actual age at
assessment. For binary outcomes, relative risks with 95% CI
were estimated using log binomial regression. For con-
tinuous outcomes, differences in means with 95% CI were
estimated using linear regression. Analyses were performed
to test for effect modiﬁcation by maternal BMI category.
Statistical signiﬁcance was set at p< 0.05 (two-sided) with
no adjustment for multiple comparisons, and all analyses
followed a pre-speciﬁed plan.
Ethics
Approval was granted by the Women’s and Children’s Local
Health Network Human Research and Ethics Committee at
the Women’s and Children’s Hospital, the Central Northern
Adelaide Health Service Ethics of Human Research Com-
mittee (Lyell McEwin Hospital) and the Flinders Clinical
Research Ethics Committee (Flinders Medical Centre). All
participants provided written informed consent to
participate.
Results
Figure 1 outlines the ﬂow of participants. A total of 2136
infants were eligible for the follow-up study and included in
the analysis (96.6% of the randomised sample). There were
1754 infants who were assessed at 6 months of age (Life-
style Advice n= 869; Standard Care n= 885), representing
82.1% of the eligible sample. There were ﬁve deaths to
6 months of age (4 neonatal deaths as reported previously
[22], and the death of one infant prior to 6 months of age
attributable to sudden infant death syndrome). Table 1
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describes the baseline characteristics of the subset of eligi-
ble maternal participants, and are similar to the entire ran-
domised cohort (data not shown) [22]. The median BMI of
the cohort was 31.0 kg/m2 (Inter Quartile Range (IQR)
27.8–35.6 kg/m2), with 42.1% of women overweight, and
57.9% obese.
There were no statistically signiﬁcant differences in the
incidence of infant BMI z-score ≥90th centile for infants
born to women in the Lifestyle Advice group, as compared
with those born to women in the Standard Care group
(Lifestyle Advice 233 (21.71%) vs. Standard Care 233
(21.90%); adjusted relative risk aRR 0.99; 95% conﬁdence
interval (CI) 0.82 to 1.18; p= 0.88), or in infant BMI z-
score ≥85th centile (Lifestyle Advice 299 (27.88%) vs.
Standard Care 303 (28.48%); aRR 0.97; 95% conﬁdence
interval (CI) 0.84 to 1.13; p= 0.71) (Table 2). Infants were
not statistically signiﬁcantly different between the two
treatment groups with regards their weight (Lifestyle
Advice 8.26 kg (±1.33) vs. Standard Care 8.29 kg (±1.33);
adjusted mean difference (aMD) −0.05; 95% CI −0.16 to
0.06; p= 0.38), weight Z-score (Lifestyle Advice 0.30
(±1.13) vs. Standard Care 0.34 (±1.11); aMD −0.04; 95%
CI −0.14 to 0.06; p= 0.43), length (Lifestyle Advice 68.24
cm (±3.76) vs. Standard Care 68.28 cm (±4.13); aMD
−0.12; 95% CI −0.41 to 0.16; p= 0.41), length Z-score
(Lifestyle Advice 0.06 (±1.22) vs. Standard Care 0.11
(±1.28); aMD −0.04; 95% CI −0.16 to 0.07; p= 0.46),
weight for length ratio (Lifestyle Advice 0.12 (±0.01) vs.
Standard Care 0.12 (±0.01); aMD −0.00; 95% CI −0.00 to
0.00; p= 0.72), or weight for length ratio Z-score (Lifestyle
Advice 0.44 (±1.18) vs. Standard Care 0.48 (±1.14); aMD
−0.04; 95% CI −0.15 to 0.07; p= 0.47). Body cir-
cumference and skin-fold thickness measures also did not
differ signiﬁcantly between infants born to women who
received the antenatal intervention, and those who received
standard care.
There were no statistically signiﬁcant differences iden-
tiﬁed between infants born to women in the Lifestyle
Advice group and those in the Standard Care group with
regards to the overall Ages and Stages total score (Lifestyle
Advice 262.47 (±34.92) vs. Standard Care 258.72
5,530 Eligible women 
approached to participate
3,318 Women declined to 
participate
2,212 Women provided 
written consent and were 
randomised
1,108 (50.09%) Women 
randomised to 
Lifestyle Advice Group
1,104 (49.91%) Women 
randomised to 
Standard Care Group
3 women withdrew consent
25 women miscarriage before 20 weeks or 
termination of pregnancy
5 women suffered stillbirth after 20 weeks
4 neonatal deaths
7 women withdrew consent
24 women miscarriage before 20 weeks or 
termination of pregnancy
6 women suffered stillbirth after 20 weeks
1 neonatal death
1 infant death <6mths age
1,071 Infants
eligible for follow-up 
study
1,065 Infants
eligible for follow-up 
study
869 infants assessed at 6 
months
1071 infants included in 
the analysis
885 infants assessed at 6 
months
1065 infants included in 
the analysis
Fig. 1 Flow of participants
Table 1 Baseline characteristics for 6 month participants
Characteristic Lifestyle
advice (N=
1071)
Standard care
(N= 1065)
Total (N=
2136e)
Maternal Age
(Years)a
29.6 (5.4) 29.8 (5.3) 29.7 (5.4)
Gestational Age at
Entry (Weeks)b
14.3
(12.0–17.0)
14.3
(12.1–17.1)
14.3
(12.0–17.4)
Body Mass Index
(kg/m2)b
31.2
(28.0–35.8)
31.0
(27.7–35.4)
31.0
(27.8–35.6)
Body Mass Index Categoryc
BMI 25.0–29.9 358 (41.2) 381 (43.1) 739 (42.1)
BMI 30.0–34.9 226 (30.2) 256 (28.9) 518 (29.5)
BMI 35.0–39.9 159 (18.3) 148 (16.7) 307 (17.5)
BMI>= 40.0 90 (10.4) 100 (11.3) 190 (10.8)
Weight (kg)a 88.3 (16.6) 88·0 (17.6) 88.1 (17.1)
Height (cm)a 164.9 (6.4) 164·7 (6.5) 164.8 (6.5)
Racec
Caucasian 790 (90.9) 802 (90.6) 1592 (90.8)
Asian 19 (2.2) 31 (3.5) 50 (2.9)
Indian 35 (4.0) 30 (3.4) 65 (3.7)
Other 25 (2.9) 22 (2.5) 47 (2.7)
Smokerc 98 (11.3) 91 (10.3) 189 (10.8)
Nulliparousc 359 (41.3) 353 (39.9) 712 (40.6)
Index of Socio-economic Disadvantaged
Unknown 1 (0.1) 1 (0.1) 2 (0.1)
Quintile 1 (Most
Disadvantaged)
256 (29.5) 251 (28.4) 507 (28.9)
Quintile 2 214 (24.6) 222 (25.1) 436 (24.9)
Quintile 3 139 (16.0) 134 (15.1) 273 (15.6)
Quintile 4 122 (14.0) 141 (15.9) 263 (15.0)
Quintile 5 (Least
Disadvantaged)
137 (15.7) 136 (15.4) 273 (15.6)
amean and standard deviation
bmedian and interquartile range
cnumber and %
dSocioeconomic index as measured by SEIFA IRSD
eIncludes all women whose infants were eligible for the 6 month
follow-up study
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(±36.54); aMD 3.53; 95% CI −0.33 to 7.40; p= 0.07), or
in the proportion of infants identiﬁed with >1 domain
below the cut-off (Lifestyle Advice 49 (4.58%) vs. Standard
Care 69 (6.51%); aRR 0.69; 95% CI 0.43 to 1.11; p= 0.13)
(Table 3). Similarly, there were no statistically signiﬁcant
differences between the two groups with regards to the
individual components of the Ages and Stages score
(Table 3).
There were no signiﬁcant differences between the two
treatment groups with regards to infant feeding patterns,
with 59.80% of infants still being breast fed at 6 months of
age (Lifestyle Advice 324 (59.12%) vs. Standard Care 347
(60.45%); aRR 1.01; 95% CI 0.97 to 1.05; p= 0.60).
Similarly, there were no signiﬁcant differences identiﬁed
with regards to general health or health service utilisation
(Table 4).
There was no evidence to suggest that the effect of the
antenatal intervention was modiﬁed by maternal BMI
category for any of the reported outcomes (data not shown).
In addition, results were compared to those of analyses
using unimputed data, and (for the primary outcome) to the
results of sensitivity analyses using data imputed under
various MNAR assumptions. The results, in terms of both
direction and magnitude of effect, were consistent across all
of these analyses.
Discussion
Our ﬁndings indicate that provision of an antenatal dietary
intervention for overweight or obese women was not
associated with effects on infant growth, measures of
adiposity, and neurodevelopmental outcomes at 6 months of
age. There was no evidence to suggest that the effects of the
intervention were modiﬁed by maternal BMI category.
Our ﬁndings represent the largest, most extensive, and
most complete follow-up of infants to 6 months of age who
were born to overweight and obese women following the
conduct of the largest randomised trial to date evaluating the
provision of a comprehensive antenatal dietary and lifestyle
intervention. We have utilised robust methodology in terms
of obtaining accurate measurement of early pregnancy
weight, height, and BMI; detailed maternal dietary and
physical activity history; and have delivered the antenatal
intervention in a consistent manner to participants. Fur-
thermore, we have utilised robust methodology to obtain
anthropometric measures of the infants at 6 months of age,
adhering to a standardised, research quality protocol.
A number of techniques have been described in the
assessment of early infant body composition. Measurement
of infant skinfold thickness [36, 37] and bio-impedance are
considered reliable and relatively non-invasive methods of
assessing fat distribution, both of which have been corre-
lated with more invasive measures [36, 38–40]. Further-
more, percentage fat, as determined by skinfold thickness
measurements has been validated against DXA calculations
of fat mass in both infants and children [36, 41]. Although
these more detailed body composition assessment tools may
have yielded more accurate estimates of the relative pro-
portions of adipose and lean tissue mass, they were not
considered feasible for use in the large scale setting required
for this follow-up study, and its associated practical and
ﬁnancial constraints.
Similarly, the use of the Ages and Stages questionnaire is
considered a screening tool to identify infants at risk of
neurodevelopmental delay [31]. While the use of a more
sensitive test would provide more detailed and accurate
estimates of early neurodevelopmental achievement, the
ASQ has been validated against robust assessment tools
[32], and in a paediatric population [33]. Again, the
resources and intensive psychology training required to
Table 3 6 month infant neurodevelopmental outcomes by treatment group, assessed by the Ages and Stages Questionnaire
Outcome Lifestyle advice
(N= 1071)
Standard care
(N= 1065)
Unadjusted treatment
effect (95% CI)
Unadjusted P-
value
Adjusted treatment
effect (95% CI)
Adjusted P-
value
Communication domain 51.30 (9.03) 50.95 (9.63) 0.35 (−0.68, 1.38) 0.501 0.36 (−0.67, 1.38) 0.493
Gross motor domain 53.35 (10.05) 52.74 (10.84) 0.61 (−0.54, 1.75) 0.297 0.55 (−0.59, 1.69) 0.344
Fine motor domain 52.25 (10.52) 51.20 (10.74) 1.05 (−0.11, 2.21) 0.075 1.00 (−0.13, 2.14) 0.082
Problem solving domain 53.60 (9.55) 52.86 (9.15) 0.74 (−0.29, 1.76) 0.158 0.72 (−0.31, 1.74) 0.170
Social domain 51.71 (9.52) 50.95 (9.74) 0.77 (−0.34, 1.87) 0.173 0.69 (−0.41, 1.79) 0.218
Total score 262.47 (34.92) 258.72 (36.54) 3.75 (−0.13, 7.63) 0.058 3.53 (−0.33, 7.40) 0.073
More than 1 score below
cut-off*
49 (4.58) 69 (6.51) 0.70 (0.44, 1.12) 0.137 0.69 (0.43, 1.11) 0.126
Values are mean and standard deviation (or number and percentage), and treatment effects are differences in means (or relative risks) and are based
on imputed data including all infants who were eligible for the follow-up study
Adjusted analyses included the stratiﬁcation variables BMI category, parity and centre. Outcomes were additionally adjusted for maternal age,
socioeconomic status and maternal smoking
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administer, for example, the more complex Bayley Scale,
while generating more detailed information, was not con-
sidered feasible in our study population.
A potential limitation of our follow-up study is the risk of
selection bias, with only 82% of the available cohort con-
tributing data at 6-month follow-up assessments. We con-
sider this risk, and the impact on the validity of our ﬁndings
to be low. Characteristics of the women and infants for
whom data was available and who participated in the 6-
month follow-up study were similar between the two ran-
domised treatment groups, and similar to the full rando-
mised cohort [22]. Further, analyses were based on all
infants who were eligible for follow-up (96.6% of those
randomised) by using multiple imputation to address
missing data for infants who were not assessed at 6 months.
Our ﬁndings indicate no evidence of an effect of a
comprehensive dietary and lifestyle intervention provided
during pregnancy for women who are overweight or obese,
on measures of infant growth, adiposity, and neurodeve-
lopment at 6-months of age. This is despite our previously
published ﬁndings of signiﬁcant but modest improvements
in maternal diet and physical activity during pregnancy
[21], and an 18 and 41% relative reduction in risk of infant
birth weight above 4 [22] and 4.5 kg, respectively [23].
While this may reﬂect evidence of a true lack of persisting
effect of maternal dietary modiﬁcation and birth weight on
weight at 6-months of age, it may also be indicative that
other factors are of relatively greater importance in driving
early, ex-utero, infant growth and development.
Previous evidence on the longer-term effects of antenatal
dietary and lifestyle interventions is limited. Vinter and
colleagues [18] conducted a follow-up assessment of par-
ticipants 6-months after birth, in which an antenatal dietary
and lifestyle intervention was provided to overweight and
obese women [15]. Although an assessment was conducted
at 6 months post-partum involving 66% of participants [18],
there have been no early infant outcomes reported to date.
Follow-up of a smaller proportion of child participants at 2
to 3 years of age [42, 43] demonstrated no signiﬁcant dif-
ferences in the metabolic proﬁle of children [42], or on
measures of growth and adiposity [43].
The ROLO trial evaluated the effect of a low glycaemic
index diet among women who had previously given birth to
an infant with weight above 4 kg [16]. While not all women
who participated in this trial were overweight or obese
(mean BMI 26.8 kg/m2), there was no evidence of an effect
on infant birth weight [16]. Furthermore, follow-up of 280
infants (35% of the randomised cohort) at 6-months of age
demonstrated no evidence of an effect of the intervention on
early infant measures of growth or adiposity [19].
The UPBEAT trial evaluated the effect of an antenatal
dietary and lifestyle intervention among obese women, with
no impact on infant birth weight demonstrated [17].Ta
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However, recently published ﬁndings from approximately
46% of eligible infants at 6 months of age (698 of 1522
eligible infants assessed) suggest a very small reduction in
subscapular skinfold thickness measurement of ~0.4 mm
following provision of the antenatal intervention [20].
While statistically signiﬁcant, the clinical signiﬁcance of
such a small difference is questionable, the ﬁndings also
consistent with a chance occurrence, particularly as this was
a secondary outcome, and no other statistically signiﬁcant
differences were identiﬁed between the treatment groups in
infant BMI, abdominal circumference, or the remainder of
infant anthropometric measures obtained.
There is emerging evidence, both from animal and
human studies, of an association between maternal obesity
and signiﬁcantly higher risks of impaired offspring cogni-
tive, motor and behavioural aspects of neurodevelopment
[44–46]. Children born to women who are overweight or
obese are more likely to be identiﬁed with moderate to
severe cognitive, motor and global developmental delay at 3
years of age [46], as well as poorer academic achievement
extending to 14 years of age [44, 45]. Autism spectrum
disorders in childhood have also been observed and diag-
nosed more frequently among children born to women with
metabolic conditions identiﬁed during pregnancy, including
diabetes and obesity [47]. Our ﬁndings report, for the ﬁrst
time, the impact of an antenatal dietary intervention for
women who are overweight or obese on early infant neu-
rodevelopment. While we did not identify statistically or
clinically signiﬁcant differences in neurodevelopment at 6-
months of age using a reliable screening tool, ongoing
follow-up of participants further into childhood will again
be important to determine whether there are any potential
beneﬁts of improving maternal diet and physical activity
during pregnancy on childhood neurodevelopment.
Conclusions
Antenatal dietary and lifestyle advice did not alter infant
growth and adiposity at 6-months of age. Despite this, it
remains important to continue to follow-up the children
whose mothers participated in this intervention trial, parti-
cularly in view of the well recognised association between
high-infant birth weight and subsequent childhood obesity
[48], and the emerging associations between maternal
obesity and impaired childhood neurodevelopmental func-
tion [46]. It will be valuable to utilise our clinical and
biological databases to explore potential pathways whereby
maternal obesity contributes to childhood outcomes,
including obesity and impaired neurodevelopment.
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